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Purpose: The aim of this study was to investigate the immunomodulatory effects of canine periodontal ligament stem cells 
on allogenic and xenogenic immune cells in vitro.
Methods:  Mixed cell cultures consisting of canine stem cells (periodontal ligament stem cells and bone marrow stem cells) 
and allogenic canine/xenogenic human peripheral blood mononuclear cells (PBMCs) were established following the addition 
of phytohemagglutinin. The proliferation of PBMCs was evaluated using the MTS assay. The cell division of PBMCs was ana-
lyzed using the CFSE assay. The apoptosis of PBMCs was assessed using the trypan blue uptake method.
Results:  Periodontal ligament stem cells and bone marrow stem cells inhibited the proliferation of allogenic and xenogenic 
PBMCs. Both periodontal ligament stem cells and bone marrow stem cells suppressed the cell division of PBMCs despite the 
existence of a mitogen. No significant differences in the percentages of apoptotic PBMCs were found among the groups.
Conclusions:  Canine periodontal ligament stem cells have an immunomodulatory effect on allogenic and xenogenic PBMCs. 
This effect is not a product of apoptosis of PBMCs but is caused by the inhibition of cell division of PBMCs.
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INTRODUCTION 
Mesenchymal stem cells (MSCs), which are nonhemato-
poietic multipotent stem cells, can differentiate into various 
types of progeny and are continuously self-renewing. MSCs 
suppress the activation of the immune reaction both in vivo 
and in vitro, known as “immunomodulation” or “immuno-
suppression.” Several studies have demonstrated the immu-
nomodulatory effects of MSCs on both allogenic and xeno-
genic immune cells [1,2]. This immunomodulatory capacity 
of MSCs has roused clinical interest in the medical field for 
areas such as hematopoietic stem cell transplantation [3]. 
However, the mechanisms involved in these activities are 
not yet completely understood. 
In the field of dentistry, periodontal ligament stem cells 
(PDLSCs) have been considered to have therapeutic potential 
for the reconstruction of tissues destroyed by periodontal 
diseases. PDLSCs are highly proliferative and capable of re-
generating cementum- and PDL-like tissues [4]. When stem 
cells from the root apical papilla and PDLSCs were transplant-
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ed into an animal model, a root/periodontal complex was 
generated [5,6]. Though the gold standard for periodontal tis-
sue engineering is autologous PDLSCs, these cells may be 
unavailable in edentulous or medically compromised patients. 
In these cases, either allogenic or xenogenic PDLSCs can be 
an alternative source. However, allogenic or xenogenic cell 
transplantation still has the potential risk of a host immune 
response against the donor tissue.  
The purpose of this study was to investigate the immuno-
modulatory effects of canine PDLSCs on allogenic and xeno-
genic immune cells, i.e., peripheral blood mononuclear cells 
(PBMCs). 
MATERIALS AND METHODS 
Animals
Five adult male beagle dogs (one year of age), weighting 10 
to 12 kg, were used for the experiments. The animal research 
protocol was approved by the Institute of Laboratory Animal 
Resources, Seoul National University (SNU-100126-6).
Isolation and culture of canine PDLSCs and BMSCs
Two beagle dogs were purchased from Central Lab. Animal 
Inc. (Seoul, Korea) from which to isolate canine PDLSCs and 
bone marrow stem cells (BMSCs). These dogs were anesthe-
tized with an intramuscular injection of 5 mg/kg xylazine 
(Rompun, Yuhan, Seoul, Korea) and 10 mg/kg ketamine (Ket-
amin, Yuhan, Seoul, Korea). The area around the iliac crest 
was depilated by an electric shaver and disinfected with beta-
dine for bone marrow aspiration. Local anesthesia in the form 
of a 2% lidocaine solution (Lignospan, Septodont Lab., Saint-
Maur-des-Fosses, France) was administered on the teeth to 
be extracted.
To collect the canine BMSCs, bone marrow aspirates of 1 
mL were taken from the iliac crest of a beagle dog. A BMSC 
culture was performed in accordance with the technique de-
scribed by Tsutsumi et al. [7]. Briefly, the cells, including 
erythrocytes, from bone marrow aspirates were seeded at 
2×10
8 cells in 100 mm tissue culture dishes and maintained 
in 10 mL of Dulbecco’s modified Eagle’s medium (Invitrogen, 
Carsbad, CA, USA) supplemented with 10% fetal bovine se-
rum (Invitrogen, Carlsbad, CA, USA), 100 U/mL penicillin and 
100 µg/mL streptomycin. Three days after seeding, the float-
ing cells were removed. The medium was replaced every 
three days. Passage was performed when cells were ap-
proaching confluence. Cells were seeded at 5×10
3 cells/cm
2 
and maintained in media containing 3 ng/mL FGF-2 (Invitro-
gen, Carlsbad, CA, USA) for two weeks. The cells were har-
vested prior to confluence by means of a sterile trypsin-
EDTA (Invitrogen, Carlsbad, CA, USA) solution (0.5 g/L tryp-
sin, 0.2 g/L EDTA in normal phosphate buffered saline, pH 
7.4) and were stored in liquid nitrogen until use.
To obtain the canine PDLSCs, all mandibular premolars 
and first molars of a beagle dog were extracted bilaterally. 
The PDL was gently separated from the root surface of the 
middle thirds of the extracted mandibular premolars and 
first molars. Following separation, the PDLSC culture was 
performed in accordance with the technique described by 
Seo et al. [4]. The obtained PDL was digested in a solution of 
3 mg/mL collagenase type I and 4 mg/mL dispase for 1 hour 
at 37°C. Single cell suspensions were obtained by filtration 
through a 70 µm strainer (BD Biosciences, Bedford, MA, 
USA). The cells were collected and stored in liquid nitrogen 
until use. In this study, cell passages 2-4 were used for the ex-
periments. 
Isolation of canine and human PBMCs
Canine whole blood was collected from beagle dogs that 
were purchased from Gaoyao Kangda Laboratory Animal 
Sciences & Technology Co. (Guangdong, China). Human 
whole blood was drawn from 10 healthy male volunteers 
(mean age 30) under a protocol approved by the Institutional 
Review Board, Seoul National University Dental Hospital 
(CRI09028). 
PBMCs were acquired by means of gradient centrifugation 
separation. Fresh heparinized peripheral blood was diluted 
with an equal volume of balanced salt solution (Invitrogen, 
Carlsbad, CA, USA). The diluted blood was layered on Ficoll-
Paque Plus (Amersham Biosciences, Wikströms, Sweden) and 
centrifuged at 400×g for 40 minutes. The buffy coat layer was 
separated and washed three times with HBSS (Invitrogen, 
Carlsbad, CA, USA). The deposited cells were resuspended in 
Roswell Park Memorial Institute (RPMI)-1640 medium (Invi-
trogen, Carlsbad, CA, USA) containing 10% fetal bovine serum, 
100 U/mL penicillin, and 100 µg/mL streptomycin.
Mixed cell cultures
Mixed cell cultures were designed as follows. Canine 
PDLSCs and BMSCs were used as stimulators, while the allo-
genic canine and xenogenic human PBMCs were used as re-
sponders. All experiments were performed in 200 µL RPMI-
1640 medium (Invitrogen, Carlsbad, CA, USA) using a 48-well 
flat bottom plate (Nunc, Roskilde, Denmark) and were run in 
triplicate. 
Stimulator canine PDLSCs and BMSCs were inactivated by 
mitomycin C (15 µg/mL, 2 hours at 37°C; Sigma-Aldrich, St. 
Louis, MO, USA). These cells (1×10
5) were co-cultured with 
canine and human PBMCs (1×10
5) following mitogenic stim-
ulation with 5 and 0.625 µg/mL phytohemagglutinin (PHA; 
Sigma-Aldrich, St. Louis, MO, USA), respectively. Optimal Journal of Periodontal
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stimulant concentrations and culture times were determined 
via preliminary kinetic experiments in which four groups 
were designed: 1) canine PDLSCs+allogenic canine PBMCs, 2) 
canine PDLSCs+xenogenic human PBMCs, 3) canine BMSCs+ 
allogenic canine PBMCs, 4) canine BMSCs+xenogenic human 
PBMCs. Canine and human PBMCs with mitogenic PHA 
stimulation were used as the negative control. Demecolcine 
(100 ng/mL; Colcemid, Sigma-Aldrich, St. Louis, MO, USA), a 
cell-cycle arresting agent, was applied as a positive control. 
MTS assays for proliferation of PBMCs
After five days in culture, the proliferation of PBMCs was 
analyzed using an MTS (Promega, Madison, WI, USA) assay 
according to the manufacturer’s protocol. The absorbance at 
490 nm was read using an ELISA plate reader (Thermomax, 
Molecular Devices Co., Menlo Park, CA, USA), and the prolif-
eration indexes were calculated relative to the OD value of 
the positive control.
CFSE assays for cell division of PBMCs 
PBMCs were labeled with 2 µM carboxyfluorescein diace-
tate succinimidyl ester (CFSE; Invitrogen, Eugene, OR, USA) 
before being added to the mixed cell culture [8]. After five days 
in mixed cell culture, PBMCs were analyzed using flow cy-
tometry (FACSCalibur, Becton Dickinson, San Diego, CA, USA) 
to detect green fluorescence (CFSE). Analysis of cell division 
was performed using ModFit software (VMac3.1 SP2, Verity 
Software House Inc., Topsham, ME, USA).
Trypan blue uptake methods for apoptosis of PBMCs
After five days in culture, PBMCs were harvested and sus-
pended in 0.4% trypan blue. The number of cells colored by 
trypan blue, representing apoptotic cells, was counted. The 
percentage of trypan blue positive cells to total cells was cal-
culated.
Statistical analysis
All values are expressed as mean±SD. The Student’s t-test 
for paired data was used to test the probability of significant 
differences between samples. P-values <0.05 are considered 
statistically significant.
RESULTS
In order to examine whether PDLSCs could inhibit the pro-
liferation of allogenic and xenogenic PBMCs despite mito-
gen stimulation, canine PDLSCs pretreated with mitomycin 
C were co-cultured with PHA-stimulated allogenic canine 
and xenogenic human PBMCs. BMSCs were also used in the 
same procedures in order to compare the immunomodula-
tory effects of PDLSCs. 
Statistically significant reductions in the proliferation in-
dexes of allogenic and xenogenic PBMCs were found in 
mixed cell cultures including PDLSCs (Fig. 1). The reduced 
values of all experimental groups, i.e., mixed cell cultures with 
stem cells, were nearly the same as the values of the positive 
control. The degrees of reduction in the proliferation indexes 
of the PDLSC groups were similar to those of the BMSC 
groups in both allogenic (Fig. 1A) and xenogenic (Fig. 1B) mixed 
cell cultures.
We also examined the cell division of PHA-stimulated 
PBMCs co-cultured with or without PDLSCs and BMSCs 
(Fig. 2). In the groups of PHA-stimulated canine and human 
PBMCs without stem cells, the peak generation phases of cell 
Figure 1.  Inhibition of the proliferation of allogenic and xenogenic peripheral blood mononuclear cells (PBMCs) when co-cultured with 
periodontal ligament stem cells (PDLSCs) and bone marrow stem cells (BMSCs), as evaluated in MTS assays. (A) Allogenic mixed cell cul-
tures (canine stem cells+allogenic canine PBMCs). (B) Xenogenic mixed cell cultures (canine stem cells+xenogenic human PBMCs). 
cPBMCs: canine PBMCs, hPBMCs: human PBMCs, cPDLSCs: canine PDLSCs, cBMSCs: canine BMSCs. 
*Significantly different from nega-
tive control (P<0.05).
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division were G3 and G7, respectively. However, in the pres-
ence of PDLSCs and BMSCs, cell division peaked at G0, i.e., 
in the parent cells. The histogram of CFSE assays in the PDLSC 
groups showed slightly different patterns when compared to 
the BMSC groups. The populations in the PDLSC groups 
shifted more to the left than the BMSC groups in both allo-
genic (Fig. 2A) and xenogenic (Fig. 2B) co-cultures.
To measure the apoptosis of PBMCs after PHA stimulation, 
trypan blue uptake methods were used (Fig. 3). In all groups, 
no significant differences in the percentages of trypan blue-
positive PBMCs were found.
DISCUSSION
Recently, the identification of MSC-like populations, such 
as PDLSCs, from dental tissues has indicated the possibility 
of applications to tissue engineering [9]. These techniques 
have the potential to develop into new methods for regener-
ative periodontal therapy. In previous studies [10,11], we found 
that canine PDLSCs are similar to human PDLSCs and other 
MSCs with respect to clonality, surface antigen profiles, and 
generation of multiple types of differentiated cells. In addi-
tion, it was demonstrated that transplantation of autologous 
Figure 3. Trypan blue uptake methods for the assessment of apoptosis of peripheral blood mononuclear cells (PBMCs). (A) Allogenic mixed 
cell cultures (canine stem cells+allogenic canine PBMCs). (B) Xenogenic mixed cell cultures (canine stem cells+xenogenic human PBMCs). 
In all groups, no significant differences in the percentages of trypan blue positive PBMCs were found. cPBMC: canine PBMC, hPBMC: hu-
man PBMC, cPDLSC: canine periodontal ligament stem cell, cBMSC: canine bone marrow stem cell.
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Figure 2. The cell division analysis of allogenic and xenogenic peripheral blood mononuclear cells (PBMCs) when co-cultured with peri-
odontal ligament stem cells and bone marrow stem cells, evaluated using CFSE assays. (A) Allogenic mixed cell cultures (canine stem 
cells+allogenic canine PBMCs). (B) Xenogenic mixed cell cultures (canine stem cells+xenogenic human PBMCs). cPBMC: canine PBMC, 
hPBMC: human PBMC, cPDLSC: canine periodontal ligament stem cell, cBMSC: canine bone marrow stem cell.
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canine PDLSCs and BMSCs enhanced alveolar bone regen-
eration in canine peri-implant defects [11].
The clinical challenges of stem cell-based periodontal ther-
apy include immune rejection after administration, the on-
cogenic properties of stem cells, and the functional integra-
tion of transplanted tissues into the host [12]. High among 
these challenges is the nullification of the immune reaction. 
The use of autologous stem cells is regarded as a standard 
solution. However, allogenic and xenogenic PDLSCs have 
some advantages over autologous PDLSCs since their use is 
limited by the difficulties of patient age, tissue quality, and 
the disease status of the patient [13].
However, MSCs can modulate the actions of immune cells 
including antigen presenting cells (APCs), dendritic cells, T 
cells, B cells, and natural killer (NK) cells [14]. This MSC capac-
ity has been shown to reduce the numbers of both allogenic 
and xenogenic immune cells [15,16]. PDLSCs have shown 
similar properties to those of canine [10] and human MSCs 
[13]. Therefore, we presumed that PDLSCs could also have 
immunomodulatory effects on allogenic and xenogenic im-
mune cells.
In the present study, not only did PDLSCs inhibit the prolif-
eration of allogenic and xenogenic PBMCs that had been 
stimulated by PHA, but this inhibition was similar to that of 
BMSCs. There was complete suppression of PBMC prolifera-
tion by colcemid (positive control), and the proliferation in-
dexes of the groups that were co-cultured with stem cells 
were almost the same as that of the positive control. In addi-
tion, this inhibition was not related to the apoptosis of PBMCs 
because all groups showed 20-30% apoptosis rates that were 
not statistically different. Instead of apoptosis of PBMCs, the 
stem cells suppressed the proliferation of PBMCs by inhibit-
ing the cell division of PBMCs in mixed cell cultures. Both 
PDLSCs and BMSCs arrested the division of PBMCs, and the 
most abundant generation of PBMCs after co-culture was 
that of the parent cell. These results are in accordance with 
those of previous studies [2,13,17]. In this study, the histogram 
of PDLSCs in CFSE assays showed a slight shift towards the 
left side in allogenic and xenogenic co-cultures, when com-
pared to BMSCs. This finding demonstrates that PDLSCs 
show slightly less of an inhibitory effect on cell division of 
PBMCs than BMSCs. This result seems to be related to the 
statement that PDLSCs are more differentiated than BMSCs 
[18,19].
Most studies agree that soluble factors are involved in the 
immunomodulation of MSCs [1,20-22]. The suppressive fac-
tors are not constitutively secreted by MSCs; rather they re-
quire dynamic cross communication between MSCs and 
immune cells [14]. In contrast, the inhibitory effect of MSCs 
on NK-cells required cell-to-cell contact, suggesting differ-
ent mechanisms for this MSC-mediated NK-cell suppression 
[22]. Several possible mechanisms have been proposed for 
MSC-mediated immunomodulation, including TGF-β1, HGF, 
cytokines (produced by MSCs), SDF-1, RANK-L, and PGE2, as 
well as osteoprotegerin (OPG) interactions and indoleamine 
2,3-dioxygenase (IDO) induced by INF-γ [1,23-27]. The acti-
vated human PBMCs induced PDLSCs to secrete soluble fac-
tors to mediate, in part, the suppression of the PBMC prolif-
eration. The resulting upregulated expressions of TGF-β1, 
HGF, and IDO (after stimulation with INF-γ) were seen in the 
mixed cell cultures of all mesenchymal stem cell types [13].
The results associated with MSC-induced inhibition of im-
mune cells are somewhat contradictory and may include 
various suppressive mechanisms. Those varying results may 
be due to multifactorial issues including model systems, en-
riched cell populations, or unfractionated PBMCs, as well as 
the different species and sources of MSCs. Other laboratory 
parameters include isolation protocol, variable timings for 
measurements, and the lack of a clear-cut definition of MSCs 
[28].
In summary, canine PDLSCs have an immunomodulatory 
effect on allogenic and xenogenic PBMCs. This effect is not 
due to apoptosis of PBMCs but to inhibition of the cell divi-
sion of PBMCs. These results suggest the potential applica-
tion of allogenic and xenogenic PDLSCs for periodontal tis-
sue regeneration. The present study is the first to study xeno-
genic immune cell inhibition by PDLSCs. Future studies are 
needed to investigate the mechanisms of immunomodula-
tion of PDLSCs. Additional in vivo studies using animal mod-
els are also needed.
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